Alkem Laboratories Ltd (ALKEM)

Company profile

Sector

Pharmaceuticals

Industry

Pharmaceuticals & Biotechnology

Market cap (₹ Cr)

64,553.14

Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 16,871 full-time employees. The company went IPO on 2015-12-23. The firm is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The firm offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Company’s product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The firm operates through a segment, Pharmaceuticals. The company has approximately 21 manufacturing facilities at multiple locations in India and the United States. The firm has approximately 800 brands and operates in 40 countries.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 5,013.5

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E

26.04

52-week high

5,933.5

52-week low

4,811

Revenue CAGR, 3 years (%)

8.25

Revenue CAGR, 5 years (%)

10.66

EPS CAGR, 3 years (%)

32.74

EPS CAGR, 5 years (%)

7.75

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter

51.2%

FII

10.16%

DII

21.4%

Public

17.25%

Promoter shares pledged

0%

Source: finedge · as of 2026-03-31

Similar companies

• Glenmark Pharmaceuticals Ltd₹ 65,075.51 Cr
• Biocon Ltd₹ 69,262 Cr
• Gland Pharma Ltd₹ 46,509.56 Cr
• IPCA Laboratories Ltd₹ 45,531.03 Cr
• GlaxoSmithKline Pharmaceuticals Ltd₹ 45,206 Cr
• Ajanta Pharma Ltd₹ 42,842.3 Cr

Source: quantro_company_profiles · as of 2026-10-23

Recent exchange filings

• concall2026-08-20
• concall2026-06-01
• concall2026-02-16
• quarterly_result2026-02-13
• concall2025-11-19

Source: nse · as of 2026-10-05

Frequently asked questions

What does Alkem Laboratories Ltd do?

Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 16,871 full-time employees. The company went IPO on 2015-12-23. The firm is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The firm offers its products across various therapeutic areas, such as Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, and Vitamins, Mineral and Nutrition. Its product range includes Rx Products, Alkem Generics and OTC Product. The Company’s product portfolio includes brands, such as Clavam, Pan, Pan-D, Taxim-O, A To Z NS, Xone, Taxim, Gemcal, Pipzo and Ondem. The firm operates through a segment, Pharmaceuticals. The company has approximately 21 manufacturing facilities at multiple locations in India and the United States. The firm has approximately 800 brands and operates in 40 countries.

Which sector is Alkem Laboratories Ltd in?

Alkem Laboratories Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.

What are Alkem Laboratories Ltd's latest annual revenue and profit?

For the year ended Mar 2026: revenue 14712.27 Cr, profit after tax 2301.80 Cr.

What is the promoter holding and pledge in Alkem Laboratories Ltd?

Promoter holding is 51.20%; pledged shares are 0.00% of the promoter holding.

Which companies are similar to Alkem Laboratories Ltd?

Companies in the same sector of similar size: Glenmark Pharmaceuticals Ltd, Biocon Ltd, Gland Pharma Ltd, IPCA Laboratories Ltd, GlaxoSmithKline Pharmaceuticals Ltd, Ajanta Pharma Ltd.